2002
DOI: 10.1331/108658002762063745
|View full text |Cite
|
Sign up to set email alerts
|

Combination Antiplatelet Therapy: Implications for Pharmacists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…44 Finally, physicians and pharmacists should be aware of recent evidence from randomized, controlled trials that led to changes in the national guidelines for indications of antiplatelet therapy for atherosclerotic diseases and counsel their patients about appropriate antiplatelet therapy. 45…”
Section: Discussionmentioning
confidence: 99%
“…44 Finally, physicians and pharmacists should be aware of recent evidence from randomized, controlled trials that led to changes in the national guidelines for indications of antiplatelet therapy for atherosclerotic diseases and counsel their patients about appropriate antiplatelet therapy. 45…”
Section: Discussionmentioning
confidence: 99%